OBX — Obsidian Therapeutics Share News
0.000.00%
- $861.11m
- $861.11m
Brief: Galera Therapeutics Reports Q1 Loss Per Share $0.58
Brief: Galera Announces Plan To Submit Avasopasem NDA By Year End
Galera Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Galera Announces Topline Results From Phase 2A Aesop Trial Of Avasopasem For Chemoradiotherapy-Induced Esophagitis
U.S. STOCKS ON THE MOVE-Halliburton, Couchbase, Newmont, Wingstop, Chevron
Galera Therapeutics rises as Q4 net loss narrows
Galera Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Galera Reports Fourth Quarter And Full Year 2021 Financial Results And Recent Corporate Updates
Galera Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Roblox, CMC Materials, Eli Lilly, energy stocks
U.S. STOCKS ON THE MOVE-Eli Lilly, Aspen Group, Nucor, Galera Therapeutics
U.S. STOCKS ON THE MOVE-Eli Lilly, Lowe's, Ocugen, Chinese stocks
U.S. STOCKS ON THE MOVE-Booking Holdings, Galera Therapeutics, Chinese stocks
Galera extends rally, BTIG upgrades to "buy"
U.S. RESEARCH ROUNDUP- Azek Company, Galera Therapeutics, Vivint Smart Home
U.S. STOCKS ON THE MOVE-Tesla, MGM Resorts, Planet Labs, Beyond Meat
U.S. STOCKS ON THE MOVE-Planet Labs, Beyond Meat, Galera Therapeutics, Cloudflare
U.S. STOCKS ON THE MOVE-Tesla, Weibo, Beyond Meat, pharma stocks
U.S. STOCKS ON THE MOVE-Tesla, Beyond Meat, Novavax, Chinese stocks